David Alan Campbell, President and CEO: Janux Therapeutics JANX Sell · Filed 01/02

Trade details

Type: Insider sale
Amount: $110,828.56
Shares · price: 8,072 sh · $13.73 a share
Held after: 284,982 sh
Stock: Janux Therapeutics JANX
Person: David Alan CampbellPresident and CEO
Trade date: 26/01/02
Filed: 26/01/02
Days to filing: 0 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/03~02/01

David Alan Campbell's recent trades

David Alan CampbellPresident and CEO
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$300K
5,000 sh
$300K
Filed 25/01/08
Traded 25/01/07
David Alan CampbellOfficer
Planned sale10b5-1 planJanux Therapeutics
Planned sale10b5-1 plan
Janux Therapeutics
JANX
$300K
5,000 sh
$300K
Filed 25/01/07
Traded 25/01/07
David Alan CampbellPresident and CEO
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$1.4M
25,000 sh
$1.4M
Filed 24/12/27
Traded 24/12/24
David Alan CampbellPresident and CEO
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$1M
15,000 sh
$1M
Filed 24/12/03
Traded 24/12/03
David Alan CampbellPresident and CEO
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$940.2K
18,281 sh
$940.2K
Filed 24/11/27
Traded 24/11/25